Global Drugs for Malaria Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Drugs for Malaria, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs for Malaria, also provides the revenue of main regions and countries. Of the upcoming market potential for Drugs for Malaria, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Malaria revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Malaria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Malaria revenue, projected growth trends, production technology, application and end-user industry.
Drugs for Malaria segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs for Malaria in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Malaria industry.
Chapter 3: Detailed analysis of Drugs for Malaria companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Malariarevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
According to APO Research, The global Drugs for Malaria market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Drugs for Malaria is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Drugs for Malaria, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Drugs for Malaria, also provides the revenue of main regions and countries. Of the upcoming market potential for Drugs for Malaria, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Malaria revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Malaria market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Malaria revenue, projected growth trends, production technology, application and end-user industry.
Drugs for Malaria segment by Company
- Cipla
- Guilin Pharmaceutical
- IPCA Laboratories
- GlaxoSmithKline
- Mylan Labs
- Roche
- Novartis
- Sanofi Aventis
- Ajanta Pharma
- Aryl Aminoalcohol Compounds
- Antifolate Compounds
- Artemisinin Compounds
- Prevention
- Treatment
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drugs for Malaria in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs for Malaria industry.
Chapter 3: Detailed analysis of Drugs for Malaria companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Malariarevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: MEALA by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market Analysis by Application
1.3.1 Global Drugs for Malaria Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Global Market Growth Prospects
1.5 Global Drugs for Malaria Growth Trends by Region
1.5.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Drugs for Malaria Market Size by Region (2019-2024)
1.5.3 Drugs for Malaria Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL DRUGS FOR MALARIA MARKET DYNAMICS
2.1 Drugs for Malaria Industry Trends
2.2 Drugs for Malaria Industry Drivers
2.3 Drugs for Malaria Industry Opportunities and Challenges
2.4 Drugs for Malaria Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Drugs for Malaria Revenue by Company (2019-2024)
3.2 Global Drugs for Malaria Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Drugs for Malaria Key Company Head office and Area Served
3.4 Global Drugs for Malaria Company, Product Type & Application
3.5 Global Drugs for Malaria Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Drugs for Malaria Market CR5 and HHI
3.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
3.6.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
4 DRUGS FOR MALARIA MARKET BY TYPE
4.1 Global Drugs for Malaria Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Drugs for Malaria Market Size by Type (2019-2030)
4.3 Global Drugs for Malaria Market Size Share by Type (2019-2030)
5 DRUGS FOR MALARIA MARKET BY APPLICATION
5.1 Global Drugs for Malaria Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Drugs for Malaria Market Size by Application (2019-2030)
5.3 Global Drugs for Malaria Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Cipla
6.1.1 Cipla Comapny Information
6.1.2 Cipla Business Overview
6.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Cipla Drugs for Malaria Product Portfolio
6.1.5 Cipla Recent Developments
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Comapny Information
6.2.2 Guilin Pharmaceutical Business Overview
6.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
6.2.5 Guilin Pharmaceutical Recent Developments
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Comapny Information
6.3.2 IPCA Laboratories Business Overview
6.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
6.3.5 IPCA Laboratories Recent Developments
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Comapny Information
6.4.2 GlaxoSmithKline Business Overview
6.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments
6.5 Mylan Labs
6.5.1 Mylan Labs Comapny Information
6.5.2 Mylan Labs Business Overview
6.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Mylan Labs Drugs for Malaria Product Portfolio
6.5.5 Mylan Labs Recent Developments
6.6 Roche
6.6.1 Roche Comapny Information
6.6.2 Roche Business Overview
6.6.3 Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Roche Drugs for Malaria Product Portfolio
6.6.5 Roche Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Novartis Drugs for Malaria Product Portfolio
6.7.5 Novartis Recent Developments
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Comapny Information
6.8.2 Sanofi Aventis Business Overview
6.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
6.8.5 Sanofi Aventis Recent Developments
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Comapny Information
6.9.2 Ajanta Pharma Business Overview
6.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
6.9.5 Ajanta Pharma Recent Developments
7 NORTH AMERICA
7.1 North America Drugs for Malaria Market Size (2019-2030)
7.2 North America Drugs for Malaria Market Size by Type
7.2.1 North America Drugs for Malaria Market Size by Type (2019-2024)
7.2.2 North America Drugs for Malaria Market Size by Type (2025-2030)
7.2.3 North America Drugs for Malaria Market Share by Type (2019-2030)
7.3 North America Drugs for Malaria Market Size by Application
7.3.1 North America Drugs for Malaria Market Size by Application (2019-2024)
7.3.2 North America Drugs for Malaria Market Size by Application (2025-2030)
7.3.3 North America Drugs for Malaria Market Share by Application (2019-2030)
7.4 North America Drugs for Malaria Market Size by Country
7.4.1 North America Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Drugs for Malaria Market Size by Country (2019-2024)
7.4.3 North America Drugs for Malaria Market Size by Country (2025-2030)
7.4.4 North America Drugs for Malaria Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Drugs for Malaria Market Size (2019-2030)
8.2 Europe Drugs for Malaria Market Size by Type
8.2.1 Europe Drugs for Malaria Market Size by Type (2019-2024)
8.2.2 Europe Drugs for Malaria Market Size by Type (2025-2030)
8.2.3 Europe Drugs for Malaria Market Share by Type (2019-2030)
8.3 Europe Drugs for Malaria Market Size by Application
8.3.1 Europe Drugs for Malaria Market Size by Application (2019-2024)
8.3.2 Europe Drugs for Malaria Market Size by Application (2025-2030)
8.3.3 Europe Drugs for Malaria Market Share by Application (2019-2030)
8.4 Europe Drugs for Malaria Market Size by Country
8.4.1 Europe Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Drugs for Malaria Market Size by Country (2019-2024)
8.4.3 Europe Drugs for Malaria Market Size by Country (2025-2030)
8.4.4 Europe Drugs for Malaria Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Drugs for Malaria Market Size (2019-2030)
9.2 China Drugs for Malaria Market Size by Type
9.2.1 China Drugs for Malaria Market Size by Type (2019-2024)
9.2.2 China Drugs for Malaria Market Size by Type (2025-2030)
9.2.3 China Drugs for Malaria Market Share by Type (2019-2030)
9.3 China Drugs for Malaria Market Size by Application
9.3.1 China Drugs for Malaria Market Size by Application (2019-2024)
9.3.2 China Drugs for Malaria Market Size by Application (2025-2030)
9.3.3 China Drugs for Malaria Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Drugs for Malaria Market Size (2019-2030)
10.2 Asia Drugs for Malaria Market Size by Type
10.2.1 Asia Drugs for Malaria Market Size by Type (2019-2024)
10.2.2 Asia Drugs for Malaria Market Size by Type (2025-2030)
10.2.3 Asia Drugs for Malaria Market Share by Type (2019-2030)
10.3 Asia Drugs for Malaria Market Size by Application
10.3.1 Asia Drugs for Malaria Market Size by Application (2019-2024)
10.3.2 Asia Drugs for Malaria Market Size by Application (2025-2030)
10.3.3 Asia Drugs for Malaria Market Share by Application (2019-2030)
10.4 Asia Drugs for Malaria Market Size by Country
10.4.1 Asia Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Drugs for Malaria Market Size by Country (2019-2024)
10.4.3 Asia Drugs for Malaria Market Size by Country (2025-2030)
10.4.4 Asia Drugs for Malaria Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Drugs for Malaria Market Size (2019-2030)
11.2 MEALA Drugs for Malaria Market Size by Type
11.2.1 MEALA Drugs for Malaria Market Size by Type (2019-2024)
11.2.2 MEALA Drugs for Malaria Market Size by Type (2025-2030)
11.2.3 MEALA Drugs for Malaria Market Share by Type (2019-2030)
11.3 MEALA Drugs for Malaria Market Size by Application
11.3.1 MEALA Drugs for Malaria Market Size by Application (2019-2024)
11.3.2 MEALA Drugs for Malaria Market Size by Application (2025-2030)
11.3.3 MEALA Drugs for Malaria Market Share by Application (2019-2030)
11.4 MEALA Drugs for Malaria Market Size by Country
11.4.1 MEALA Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Drugs for Malaria Market Size by Country (2019-2024)
11.4.3 MEALA Drugs for Malaria Market Size by Country (2025-2030)
11.4.4 MEALA Drugs for Malaria Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
1.1 Product Definition
1.2 Market Analysis by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market Analysis by Application
1.3.1 Global Drugs for Malaria Market Size Growth Rate by Application: 2019 VS 2023 VS 2030
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Global Market Growth Prospects
1.5 Global Drugs for Malaria Growth Trends by Region
1.5.1 Global Drugs for Malaria Market Size by Region: 2019 VS 2023 VS 2030
1.5.2 Drugs for Malaria Market Size by Region (2019-2024)
1.5.3 Drugs for Malaria Market Size by Region (2025-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
1.8 Years Considered
2 GLOBAL DRUGS FOR MALARIA MARKET DYNAMICS
2.1 Drugs for Malaria Industry Trends
2.2 Drugs for Malaria Industry Drivers
2.3 Drugs for Malaria Industry Opportunities and Challenges
2.4 Drugs for Malaria Industry Restraints
3 COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Drugs for Malaria Revenue by Company (2019-2024)
3.2 Global Drugs for Malaria Players Revenue Ranking, 2022 VS 2023 VS 2024
3.3 Global Drugs for Malaria Key Company Head office and Area Served
3.4 Global Drugs for Malaria Company, Product Type & Application
3.5 Global Drugs for Malaria Company Commercialization Time
3.6 Market Competitive Analysis
3.6.1 Global Drugs for Malaria Market CR5 and HHI
3.6.2 Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
3.6.3 2023 Drugs for Malaria Tier 1, Tier 2, and Tier
4 DRUGS FOR MALARIA MARKET BY TYPE
4.1 Global Drugs for Malaria Market Size by Type (2019 VS 2023 VS 2030)
4.2 Global Drugs for Malaria Market Size by Type (2019-2030)
4.3 Global Drugs for Malaria Market Size Share by Type (2019-2030)
5 DRUGS FOR MALARIA MARKET BY APPLICATION
5.1 Global Drugs for Malaria Market Size by Application (2019 VS 2023 VS 2030)
5.2 Global Drugs for Malaria Market Size by Application (2019-2030)
5.3 Global Drugs for Malaria Market Size Share by Application (2019-2030)
6 COMPANY PROFILES
6.1 Cipla
6.1.1 Cipla Comapny Information
6.1.2 Cipla Business Overview
6.1.3 Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.1.4 Cipla Drugs for Malaria Product Portfolio
6.1.5 Cipla Recent Developments
6.2 Guilin Pharmaceutical
6.2.1 Guilin Pharmaceutical Comapny Information
6.2.2 Guilin Pharmaceutical Business Overview
6.2.3 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.2.4 Guilin Pharmaceutical Drugs for Malaria Product Portfolio
6.2.5 Guilin Pharmaceutical Recent Developments
6.3 IPCA Laboratories
6.3.1 IPCA Laboratories Comapny Information
6.3.2 IPCA Laboratories Business Overview
6.3.3 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.3.4 IPCA Laboratories Drugs for Malaria Product Portfolio
6.3.5 IPCA Laboratories Recent Developments
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Comapny Information
6.4.2 GlaxoSmithKline Business Overview
6.4.3 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.4.4 GlaxoSmithKline Drugs for Malaria Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments
6.5 Mylan Labs
6.5.1 Mylan Labs Comapny Information
6.5.2 Mylan Labs Business Overview
6.5.3 Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.5.4 Mylan Labs Drugs for Malaria Product Portfolio
6.5.5 Mylan Labs Recent Developments
6.6 Roche
6.6.1 Roche Comapny Information
6.6.2 Roche Business Overview
6.6.3 Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.6.4 Roche Drugs for Malaria Product Portfolio
6.6.5 Roche Recent Developments
6.7 Novartis
6.7.1 Novartis Comapny Information
6.7.2 Novartis Business Overview
6.7.3 Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.7.4 Novartis Drugs for Malaria Product Portfolio
6.7.5 Novartis Recent Developments
6.8 Sanofi Aventis
6.8.1 Sanofi Aventis Comapny Information
6.8.2 Sanofi Aventis Business Overview
6.8.3 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.8.4 Sanofi Aventis Drugs for Malaria Product Portfolio
6.8.5 Sanofi Aventis Recent Developments
6.9 Ajanta Pharma
6.9.1 Ajanta Pharma Comapny Information
6.9.2 Ajanta Pharma Business Overview
6.9.3 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
6.9.4 Ajanta Pharma Drugs for Malaria Product Portfolio
6.9.5 Ajanta Pharma Recent Developments
7 NORTH AMERICA
7.1 North America Drugs for Malaria Market Size (2019-2030)
7.2 North America Drugs for Malaria Market Size by Type
7.2.1 North America Drugs for Malaria Market Size by Type (2019-2024)
7.2.2 North America Drugs for Malaria Market Size by Type (2025-2030)
7.2.3 North America Drugs for Malaria Market Share by Type (2019-2030)
7.3 North America Drugs for Malaria Market Size by Application
7.3.1 North America Drugs for Malaria Market Size by Application (2019-2024)
7.3.2 North America Drugs for Malaria Market Size by Application (2025-2030)
7.3.3 North America Drugs for Malaria Market Share by Application (2019-2030)
7.4 North America Drugs for Malaria Market Size by Country
7.4.1 North America Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
7.4.2 North America Drugs for Malaria Market Size by Country (2019-2024)
7.4.3 North America Drugs for Malaria Market Size by Country (2025-2030)
7.4.4 North America Drugs for Malaria Market Share by Country (2019-2030)
7.4.5 United States
7.4.6 Canada
8 EUROPE
8.1 Europe Drugs for Malaria Market Size (2019-2030)
8.2 Europe Drugs for Malaria Market Size by Type
8.2.1 Europe Drugs for Malaria Market Size by Type (2019-2024)
8.2.2 Europe Drugs for Malaria Market Size by Type (2025-2030)
8.2.3 Europe Drugs for Malaria Market Share by Type (2019-2030)
8.3 Europe Drugs for Malaria Market Size by Application
8.3.1 Europe Drugs for Malaria Market Size by Application (2019-2024)
8.3.2 Europe Drugs for Malaria Market Size by Application (2025-2030)
8.3.3 Europe Drugs for Malaria Market Share by Application (2019-2030)
8.4 Europe Drugs for Malaria Market Size by Country
8.4.1 Europe Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
8.4.2 Europe Drugs for Malaria Market Size by Country (2019-2024)
8.4.3 Europe Drugs for Malaria Market Size by Country (2025-2030)
8.4.4 Europe Drugs for Malaria Market Share by Country (2019-2030)
8.4.5 Germany
8.4.6 France
8.4.7 U.K.
8.4.8 Italy
8.4.9 Russia
8.4.10 Nordic Countries
9 CHINA
9.1 China Drugs for Malaria Market Size (2019-2030)
9.2 China Drugs for Malaria Market Size by Type
9.2.1 China Drugs for Malaria Market Size by Type (2019-2024)
9.2.2 China Drugs for Malaria Market Size by Type (2025-2030)
9.2.3 China Drugs for Malaria Market Share by Type (2019-2030)
9.3 China Drugs for Malaria Market Size by Application
9.3.1 China Drugs for Malaria Market Size by Application (2019-2024)
9.3.2 China Drugs for Malaria Market Size by Application (2025-2030)
9.3.3 China Drugs for Malaria Market Share by Application (2019-2030)
10 ASIA
10.1 Asia Drugs for Malaria Market Size (2019-2030)
10.2 Asia Drugs for Malaria Market Size by Type
10.2.1 Asia Drugs for Malaria Market Size by Type (2019-2024)
10.2.2 Asia Drugs for Malaria Market Size by Type (2025-2030)
10.2.3 Asia Drugs for Malaria Market Share by Type (2019-2030)
10.3 Asia Drugs for Malaria Market Size by Application
10.3.1 Asia Drugs for Malaria Market Size by Application (2019-2024)
10.3.2 Asia Drugs for Malaria Market Size by Application (2025-2030)
10.3.3 Asia Drugs for Malaria Market Share by Application (2019-2030)
10.4 Asia Drugs for Malaria Market Size by Country
10.4.1 Asia Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
10.4.2 Asia Drugs for Malaria Market Size by Country (2019-2024)
10.4.3 Asia Drugs for Malaria Market Size by Country (2025-2030)
10.4.4 Asia Drugs for Malaria Market Share by Country (2019-2030)
10.4.5 Japan
10.4.6 South Korea
10.4.7 China Taiwan
10.4.8 Southeast Asia
10.4.9 India
10.4.10 Australia
11 MEALA
11.1 MEALA Drugs for Malaria Market Size (2019-2030)
11.2 MEALA Drugs for Malaria Market Size by Type
11.2.1 MEALA Drugs for Malaria Market Size by Type (2019-2024)
11.2.2 MEALA Drugs for Malaria Market Size by Type (2025-2030)
11.2.3 MEALA Drugs for Malaria Market Share by Type (2019-2030)
11.3 MEALA Drugs for Malaria Market Size by Application
11.3.1 MEALA Drugs for Malaria Market Size by Application (2019-2024)
11.3.2 MEALA Drugs for Malaria Market Size by Application (2025-2030)
11.3.3 MEALA Drugs for Malaria Market Share by Application (2019-2030)
11.4 MEALA Drugs for Malaria Market Size by Country
11.4.1 MEALA Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030)
11.4.2 MEALA Drugs for Malaria Market Size by Country (2019-2024)
11.4.3 MEALA Drugs for Malaria Market Size by Country (2025-2030)
11.4.4 MEALA Drugs for Malaria Market Share by Country (2019-2030)
11.4.5 Brazil
11.4.6 Mexico
11.4.7 Turkey
11.4.8 Israel
11.4.9 GCC Countries
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
13.6 Disclaimer
LIST OF TABLES
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Aryl Aminoalcohol Compounds
Table 3. Key Players of Antifolate Compounds
Table 4. Key Players of Artemisinin Compounds
Table 5. Global Drugs for Malaria Market Size Growth Rate by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Key Players of Prevention
Table 7. Key Players of Treatment
Table 8. Key Players of Others
Table 9. Global Drugs for Malaria Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Drugs for Malaria Market Share by Region (2019-2024)
Table 12. Global Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Drugs for Malaria Market Share by Region (2025-2030)
Table 14. Drugs for Malaria Industry Trends
Table 15. Drugs for Malaria Industry Drivers
Table 16. Drugs for Malaria Industry Opportunities and Challenges
Table 17. Drugs for Malaria Industry Restraints
Table 18. Global Drugs for Malaria Revenue by Company (US$ Million) & (2019-2024)
Table 19. Global Drugs for Malaria Revenue Market Share by Company (2019-2024)
Table 20. Global Drugs for Malaria Players Revenue Ranking, 2022 VS 2023 VS 2024
Table 21. Global Drugs for Malaria Key Company Head office and Area Served
Table 22. Global Drugs for Malaria Company, Product Type & Application
Table 23. Global Drugs for Malaria Company Commercialization Time
Table 24. Global Company Market Concentration Ratio (CR5 and HHI)
Table 25. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Drugs for Malaria Market Size by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Drugs for Malaria Revenue Market Share by Type (2019-2024)
Table 30. Global Drugs for Malaria Revenue Market Share by Type (2025-2030)
Table 31. Global Drugs for Malaria Market Size by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Drugs for Malaria Revenue Market Share by Application (2019-2024)
Table 35. Global Drugs for Malaria Revenue Market Share by Application (2025-2030)
Table 36. Cipla Business Overview
Table 37. Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. Cipla Drugs for Malaria Product Portfolio
Table 39. Cipla Recent Development
Table 40. Guilin Pharmaceutical Company Information
Table 41. Guilin Pharmaceutical Business Overview
Table 42. Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 44. Guilin Pharmaceutical Recent Development
Table 45. IPCA Laboratories Company Information
Table 46. IPCA Laboratories Business Overview
Table 47. IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 49. IPCA Laboratories Recent Development
Table 50. GlaxoSmithKline Company Information
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 54. GlaxoSmithKline Recent Development
Table 55. Mylan Labs Company Information
Table 56. Mylan Labs Business Overview
Table 57. Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Mylan Labs Drugs for Malaria Product Portfolio
Table 59. Mylan Labs Recent Development
Table 60. Roche Company Information
Table 61. Roche Business Overview
Table 62. Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Roche Drugs for Malaria Product Portfolio
Table 64. Roche Recent Development
Table 65. Novartis Company Information
Table 66. Novartis Business Overview
Table 67. Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. Novartis Drugs for Malaria Product Portfolio
Table 69. Novartis Recent Development
Table 70. Sanofi Aventis Company Information
Table 71. Sanofi Aventis Business Overview
Table 72. Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 74. Sanofi Aventis Recent Development
Table 75. Ajanta Pharma Company Information
Table 76. Ajanta Pharma Business Overview
Table 77. Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 79. Ajanta Pharma Recent Development
Table 80. North America Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 81. North America Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 82. North America Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 83. North America Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 84. North America Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 85. North America Drugs for Malaria Market Size by Country (2019-2024)
Table 86. North America Drugs for Malaria Market Size by Country (2025-2030)
Table 87. Europe Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 88. Europe Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 89. Europe Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 90. Europe Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 91. Europe Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 92. Europe Drugs for Malaria Market Size by Country (2019-2024)
Table 93. Europe Drugs for Malaria Market Size by Country (2025-2030)
Table 94. China Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 95. China Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 96. China Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 97. China Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 98. Asia Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 99. Asia Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 100. Asia Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 101. Asia Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 102. Asia Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. Asia Drugs for Malaria Market Size by Country (2019-2024)
Table 104. Asia Drugs for Malaria Market Size by Country (2025-2030)
Table 105. MEALA Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 106. MEALA Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 107. MEALA Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 108. MEALA Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 109. MEALA Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 110. MEALA Drugs for Malaria Market Size by Country (2019-2024)
Table 111. MEALA Drugs for Malaria Market Size by Country (2025-2030)
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Aryl Aminoalcohol Compounds
Table 3. Key Players of Antifolate Compounds
Table 4. Key Players of Artemisinin Compounds
Table 5. Global Drugs for Malaria Market Size Growth Rate by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Key Players of Prevention
Table 7. Key Players of Treatment
Table 8. Key Players of Others
Table 9. Global Drugs for Malaria Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Drugs for Malaria Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Drugs for Malaria Market Share by Region (2019-2024)
Table 12. Global Drugs for Malaria Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Drugs for Malaria Market Share by Region (2025-2030)
Table 14. Drugs for Malaria Industry Trends
Table 15. Drugs for Malaria Industry Drivers
Table 16. Drugs for Malaria Industry Opportunities and Challenges
Table 17. Drugs for Malaria Industry Restraints
Table 18. Global Drugs for Malaria Revenue by Company (US$ Million) & (2019-2024)
Table 19. Global Drugs for Malaria Revenue Market Share by Company (2019-2024)
Table 20. Global Drugs for Malaria Players Revenue Ranking, 2022 VS 2023 VS 2024
Table 21. Global Drugs for Malaria Key Company Head office and Area Served
Table 22. Global Drugs for Malaria Company, Product Type & Application
Table 23. Global Drugs for Malaria Company Commercialization Time
Table 24. Global Company Market Concentration Ratio (CR5 and HHI)
Table 25. Global Drugs for Malaria by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Drugs for Malaria Market Size by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Drugs for Malaria Revenue Market Share by Type (2019-2024)
Table 30. Global Drugs for Malaria Revenue Market Share by Type (2025-2030)
Table 31. Global Drugs for Malaria Market Size by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Drugs for Malaria Revenue Market Share by Application (2019-2024)
Table 35. Global Drugs for Malaria Revenue Market Share by Application (2025-2030)
Table 36. Cipla Business Overview
Table 37. Cipla Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 38. Cipla Drugs for Malaria Product Portfolio
Table 39. Cipla Recent Development
Table 40. Guilin Pharmaceutical Company Information
Table 41. Guilin Pharmaceutical Business Overview
Table 42. Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 43. Guilin Pharmaceutical Drugs for Malaria Product Portfolio
Table 44. Guilin Pharmaceutical Recent Development
Table 45. IPCA Laboratories Company Information
Table 46. IPCA Laboratories Business Overview
Table 47. IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 48. IPCA Laboratories Drugs for Malaria Product Portfolio
Table 49. IPCA Laboratories Recent Development
Table 50. GlaxoSmithKline Company Information
Table 51. GlaxoSmithKline Business Overview
Table 52. GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 53. GlaxoSmithKline Drugs for Malaria Product Portfolio
Table 54. GlaxoSmithKline Recent Development
Table 55. Mylan Labs Company Information
Table 56. Mylan Labs Business Overview
Table 57. Mylan Labs Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 58. Mylan Labs Drugs for Malaria Product Portfolio
Table 59. Mylan Labs Recent Development
Table 60. Roche Company Information
Table 61. Roche Business Overview
Table 62. Roche Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 63. Roche Drugs for Malaria Product Portfolio
Table 64. Roche Recent Development
Table 65. Novartis Company Information
Table 66. Novartis Business Overview
Table 67. Novartis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 68. Novartis Drugs for Malaria Product Portfolio
Table 69. Novartis Recent Development
Table 70. Sanofi Aventis Company Information
Table 71. Sanofi Aventis Business Overview
Table 72. Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 73. Sanofi Aventis Drugs for Malaria Product Portfolio
Table 74. Sanofi Aventis Recent Development
Table 75. Ajanta Pharma Company Information
Table 76. Ajanta Pharma Business Overview
Table 77. Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 78. Ajanta Pharma Drugs for Malaria Product Portfolio
Table 79. Ajanta Pharma Recent Development
Table 80. North America Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 81. North America Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 82. North America Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 83. North America Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 84. North America Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 85. North America Drugs for Malaria Market Size by Country (2019-2024)
Table 86. North America Drugs for Malaria Market Size by Country (2025-2030)
Table 87. Europe Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 88. Europe Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 89. Europe Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 90. Europe Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 91. Europe Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 92. Europe Drugs for Malaria Market Size by Country (2019-2024)
Table 93. Europe Drugs for Malaria Market Size by Country (2025-2030)
Table 94. China Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 95. China Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 96. China Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 97. China Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 98. Asia Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 99. Asia Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 100. Asia Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 101. Asia Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 102. Asia Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 103. Asia Drugs for Malaria Market Size by Country (2019-2024)
Table 104. Asia Drugs for Malaria Market Size by Country (2025-2030)
Table 105. MEALA Drugs for Malaria Market Size by Type (2019-2024) & (US$ Million)
Table 106. MEALA Drugs for Malaria Market Size by Type (2025-2030) & (US$ Million)
Table 107. MEALA Drugs for Malaria Market Size by Application (2019-2024) & (US$ Million)
Table 108. MEALA Drugs for Malaria Market Size by Application (2025-2030) & (US$ Million)
Table 109. MEALA Drugs for Malaria Market Size by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 110. MEALA Drugs for Malaria Market Size by Country (2019-2024)
Table 111. MEALA Drugs for Malaria Market Size by Country (2025-2030)
Table 112. Research Programs/Design for This Report
Table 113. Authors List of This Report
Table 114. Secondary Sources
Table 115. Primary Sources
LIST OF FIGURES
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drugs for Malaria Market Share by Type: 2023 VS 2030
Figure 4. Aryl Aminoalcohol Compounds Picture
Figure 5. Antifolate Compounds Picture
Figure 6. Artemisinin Compounds Picture
Figure 7. Global Drugs for Malaria Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Drugs for Malaria Market Share by Application: 2023 VS 2030
Figure 9. Prevention Picture
Figure 10. Treatment Picture
Figure 11. Others Picture
Figure 12. Global Drugs for Malaria Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 14. Global Drugs for Malaria Market Share by Region: 2023 VS 2030
Figure 15. Years Considered
Figure 16. Global Drugs for Malaria Market Share by Players in 2023
Figure 17. Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Drugs for Malaria Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Drugs for Malaria Revenue Market Share by Type (2019-2030)
Figure 21. Global Drugs for Malaria Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Drugs for Malaria Revenue Market Share by Application (2019-2030)
Figure 23. North America Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 24. North America Drugs for Malaria Market Share by Type (2019-2030)
Figure 25. North America Drugs for Malaria Market Share by Application (2019-2030)
Figure 26. North America Drugs for Malaria Market Share by Country (2019-2030)
Figure 27. United States Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 28. Canada Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 29. Europe Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 30. Europe Drugs for Malaria Market Share by Type (2019-2030)
Figure 31. Europe Drugs for Malaria Market Share by Application (2019-2030)
Figure 32. Europe Drugs for Malaria Market Share by Country (2019-2030)
Figure 33. Germany Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 34. France Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 35. U.K. Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 36. Italy Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 37. Russia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 39. China Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 40. China Drugs for Malaria Market Share by Type (2019-2030)
Figure 41. China Drugs for Malaria Market Share by Application (2019-2030)
Figure 42. Asia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 43. Asia Drugs for Malaria Market Share by Type (2019-2030)
Figure 44. Asia Drugs for Malaria Market Share by Application (2019-2030)
Figure 45. Asia Drugs for Malaria Market Share by Country (2019-2030)
Figure 46. Japan Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 47. South Korea Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 48. China Taiwan Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 50. India Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 51. Australia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 52. MEALA Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 53. MEALA Drugs for Malaria Market Share by Type (2019-2030)
Figure 54. MEALA Drugs for Malaria Market Share by Application (2019-2030)
Figure 55. MEALA Drugs for Malaria Market Share by Country (2019-2030)
Figure 56. Brazil Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 57. Mexico Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 58. Turkey Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 59. Israel Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 60. GCC Countries Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 61. Research Process
Figure 62. Key Executives Interviewed
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drugs for Malaria Market Share by Type: 2023 VS 2030
Figure 4. Aryl Aminoalcohol Compounds Picture
Figure 5. Antifolate Compounds Picture
Figure 6. Artemisinin Compounds Picture
Figure 7. Global Drugs for Malaria Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Drugs for Malaria Market Share by Application: 2023 VS 2030
Figure 9. Prevention Picture
Figure 10. Treatment Picture
Figure 11. Others Picture
Figure 12. Global Drugs for Malaria Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 14. Global Drugs for Malaria Market Share by Region: 2023 VS 2030
Figure 15. Years Considered
Figure 16. Global Drugs for Malaria Market Share by Players in 2023
Figure 17. Global Top 5 and 10 Drugs for Malaria Players Market Share by Revenue in 2023
Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Drugs for Malaria Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Drugs for Malaria Revenue Market Share by Type (2019-2030)
Figure 21. Global Drugs for Malaria Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Drugs for Malaria Revenue Market Share by Application (2019-2030)
Figure 23. North America Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 24. North America Drugs for Malaria Market Share by Type (2019-2030)
Figure 25. North America Drugs for Malaria Market Share by Application (2019-2030)
Figure 26. North America Drugs for Malaria Market Share by Country (2019-2030)
Figure 27. United States Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 28. Canada Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 29. Europe Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 30. Europe Drugs for Malaria Market Share by Type (2019-2030)
Figure 31. Europe Drugs for Malaria Market Share by Application (2019-2030)
Figure 32. Europe Drugs for Malaria Market Share by Country (2019-2030)
Figure 33. Germany Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 34. France Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 35. U.K. Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 36. Italy Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 37. Russia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 39. China Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 40. China Drugs for Malaria Market Share by Type (2019-2030)
Figure 41. China Drugs for Malaria Market Share by Application (2019-2030)
Figure 42. Asia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 43. Asia Drugs for Malaria Market Share by Type (2019-2030)
Figure 44. Asia Drugs for Malaria Market Share by Application (2019-2030)
Figure 45. Asia Drugs for Malaria Market Share by Country (2019-2030)
Figure 46. Japan Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 47. South Korea Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 48. China Taiwan Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 50. India Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 51. Australia Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 52. MEALA Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 53. MEALA Drugs for Malaria Market Share by Type (2019-2030)
Figure 54. MEALA Drugs for Malaria Market Share by Application (2019-2030)
Figure 55. MEALA Drugs for Malaria Market Share by Country (2019-2030)
Figure 56. Brazil Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 57. Mexico Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 58. Turkey Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 59. Israel Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 60. GCC Countries Drugs for Malaria Market Size (2019-2030) & (US$ Million)
Figure 61. Research Process
Figure 62. Key Executives Interviewed
